These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18482740)

  • 1. Exploration of the intercellular heterogeneity of topotecan uptake into human breast cancer cells through compartmental modelling.
    Cheung SY; Evans ND; Chappell MJ; Godfrey KR; Smith PJ; Errington RJ
    Math Biosci; 2008 Jun; 213(2):119-34. PubMed ID: 18482740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mathematical model for the in vitro kinetics of the anti-cancer agent topotecan.
    Evans ND; Errington RJ; Shelley M; Feeney GP; Chapman MJ; Godfrey KR; Smith PJ; Chappell MJ
    Math Biosci; 2004 Jun; 189(2):185-217. PubMed ID: 15094319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global identifiability of linear compartmental models--a computer algebra algorithm.
    Audoly S; D'Angiò L; Saccomani MP; Cobelli C
    IEEE Trans Biomed Eng; 1998 Jan; 45(1):36-47. PubMed ID: 9444838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural identifiability for a class of non-linear compartmental systems using linear/non-linear splitting and symbolic computation.
    Chapman MJ; Godfrey KR; Chappell MJ; Evans ND
    Math Biosci; 2003 May; 183(1):1-14. PubMed ID: 12604132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAISY: a new software tool to test global identifiability of biological and physiological systems.
    Bellu G; Saccomani MP; Audoly S; D'Angiò L
    Comput Methods Programs Biomed; 2007 Oct; 88(1):52-61. PubMed ID: 17707944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acid.
    Ogungbenro K; Aarons L
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):279-92. PubMed ID: 21347679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic modelling of the role of the aldehyde dehydrogenase enzyme and the breast cancer resistance protein in drug resistance and transport.
    Atari MI; Chappell MJ; Errington RJ; Smith PJ; Evans ND
    Comput Methods Programs Biomed; 2011 Nov; 104(2):93-103. PubMed ID: 20621382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Identifiability of Dynamic Systems Biology Models.
    Villaverde AF; Barreiro A; Papachristodoulou A
    PLoS Comput Biol; 2016 Oct; 12(10):e1005153. PubMed ID: 27792726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the P-glycoprotein- and breast cancer resistance protein-mediated brain penetration of 11C-labeled topotecan using small-animal positron emission tomography.
    Yamasaki T; Fujinaga M; Kawamura K; Hatori A; Yui J; Nengaki N; Ogawa M; Yoshida Y; Wakizaka H; Yanamoto K; Fukumura T; Zhang MR
    Nucl Med Biol; 2011 Jul; 38(5):707-14. PubMed ID: 21718946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On finding and using identifiable parameter combinations in nonlinear dynamic systems biology models and COMBOS: a novel web implementation.
    Meshkat N; Kuo CE; DiStefano J
    PLoS One; 2014; 9(10):e110261. PubMed ID: 25350289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced microscopy solutions for monitoring the kinetics and dynamics of drug-DNA targeting in living cells.
    Errington RJ; Ameer-Beg SM; Vojnovic B; Patterson LH; Zloh M; Smith PJ
    Adv Drug Deliv Rev; 2005 Jan; 57(1):153-67. PubMed ID: 15518927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GenSSI: a software toolbox for structural identifiability analysis of biological models.
    Chiş O; Banga JR; Balsa-Canto E
    Bioinformatics; 2011 Sep; 27(18):2610-1. PubMed ID: 21784792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A confidence building exercise in data and identifiability: Modeling cancer chemotherapy as a case study.
    Eisenberg MC; Jain HV
    J Theor Biol; 2017 Oct; 431():63-78. PubMed ID: 28733187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: To be or not to be an identifiable model. Is this a relevant question in animal science modelling?
    Muñoz-Tamayo R; Puillet L; Daniel JB; Sauvant D; Martin O; Taghipoor M; Blavy P
    Animal; 2018 Apr; 12(4):701-712. PubMed ID: 29096725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A coupled drug kinetics-cell cycle model to analyse the response of human cells to intervention by topotecan.
    Chappell MJ; Evans ND; Errington RJ; Khan IA; Campbell L; Ali R; Godfrey KR; Smith PJ
    Comput Methods Programs Biomed; 2008 Feb; 89(2):169-78. PubMed ID: 18082908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural identifiability and sensitivity.
    Iliadis A
    J Pharmacokinet Pharmacodyn; 2019 Apr; 46(2):127-135. PubMed ID: 30895420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural identifiability analyses of candidate models for in vitro Pitavastatin hepatic uptake.
    Grandjean TR; Chappell MJ; Yates JW; Evans ND
    Comput Methods Programs Biomed; 2014 May; 114(3):e60-9. PubMed ID: 23870173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DISTING: A web application for fast algorithmic computation of alternative indistinguishable linear compartmental models.
    Davidson NR; Godfrey KR; Alquaddoomi F; Nola D; DiStefano JJ
    Comput Methods Programs Biomed; 2017 May; 143():129-135. PubMed ID: 28391810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion-Pairing Contribution to the Liposomal Transport of Topotecan as Revealed by Mechanistic Modeling.
    Fugit KD; Anderson BD
    J Pharm Sci; 2017 Apr; 106(4):1149-1161. PubMed ID: 28007561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetic model for topotecan in mice.
    Shah DK; Balthasar JP
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):121-42. PubMed ID: 21104004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.